India to tackle global obesity with cheap fat-loss jabs

India is set to launch low-cost generic versions of popular weight-loss injections like Ozempic following patent expirations. This move promises to significantly expand access to these treatments, previously considered a luxury, especially in middle-income countries. Doctors anticipate a surge in patients as prices are expected to drop dramatically.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/MzOBUpK
via